Lombard Medical Inc (EVAR) reported quarterly earnings results on Wednesday, May-11-2016. The company said it had a profit of $-0.38 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $-0.40. The company posted revenue of $2.90 million in the period, compared to analysts expectations of $3.52 million. The company’s revenue was down -14.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.59 EPS.
Lombard Medical Inc opened for trading at $1.6 and hit $1.666 on the upside on Tuesday, eventually ending the session at $1.64, with a gain of 1.86% or 0.03 points. The heightened volatility saw the trading volume jump to 29,565 shares. Company has a market cap of $33 M.
Lombard Medical Inc. is a medical technology company. The Company specializes in developing manufacturing and marketing endovascular stent-grafts for repair of aortic aneurysms. Its lead product Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of up to 90 degrees. It supplies Aorfix pre-loaded into a delivery system Aorflex which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is placed within the abdominal aorta it provides a conduit for blood flow thereby relieving pressure within the weakened or aneurysmal section of the vessel wall which reduces the potential for the AAA to rupture. Its principal brands are Aorfix and Aorflex. Outside of the United States it markets Aorfix through its direct sales forces in Germany and the United Kingdom and through distribution agreements with partners in other European Union countries Latin America and Asia.